COMPANY

Spero Therapeutics, Inc.

HQ: Cambridge, MA source · sperotx.com ↗ · New England

Keywords: immunology

Location: Cambridge, MA · source · Aug 28, 2026

Profile checked Oct 10, 2026

14NIH grants

NIH awards 14

Annual award amounts. Total $12.3M.

2024 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00012-9999-1 FY2024: $3,424,537 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. D source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-3 FY2023: $104,638 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. Adv source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-4 FY2023: $1,386,775 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. A source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-7 FY2023: $21,302 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. Adva source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-2 FY2023: $14,948 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. Adva source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-5 FY2023: $1,901,006 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. A source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-6 FY2023: $29,823 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. Adva source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-1 FY2023: $1,494,630 awarded for that fiscal year; activity N01 (OTHER_NIH); PI LISTER, TROY; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-P00004-9999-8 FY2023: $34,083 awarded for that fiscal year; activity N01 (OTHER_NIH); PI KANE, BRIAN; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. Adva source ↗
2021 NIH contract (government contract; not a grant and not an investment round) 75N93021C00022-0-9999-1 FY2021: $2,089,779 awarded for that fiscal year; activity N01 (OTHER_NIH); PI LISTER, TROY; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. Advan source ↗
2019 NIH contract (government contract; not a grant and not an investment round) 272201500014C-P00014-9999-1 FY2019: $210,895 awarded for that fiscal year; activity N01 (OTHER_NIH); PI DAWSON, MICHAEL J.; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, M source ↗
Feb 23, 2018 NIH award 5R44AI131749-02 FY2018: $425,178 awarded for that fiscal year; activity R44 (SBIR); PI PUCCI, MICHAEL J; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. A Novel Gyrase Inhibitor for the Treat source ↗
2018 NIH contract (government contract; not a grant and not an investment round) 272201500014C-11-0-1 FY2018: $571,132 awarded for that fiscal year; activity N01 (OTHER_NIH); PI DAWSON, MICHAEL J.; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. Opti source ↗
Feb 22, 2017 NIH award 1R44AI131749-01 FY2017: $564,718 awarded for that fiscal year; activity R44 (SBIR); PI PUCCI, MICHAEL J; recipient as written: SPERO THERAPEUTICS, INC., CAMBRIDGE, MA. A Novel Gyrase Inhibitor for the Treat source ↗